Cell line | Cancer type | LOH | TAI | LST | ploidy | HRD score | BRCA1/2 mutation | BRCA1-methylation (%) |
---|---|---|---|---|---|---|---|---|
HCC38 | BRCA | 30 | 24 | 71 | 3.34 | 73.21 | WT | 74.33 |
HCC1806 | BRCA | 34 | 23 | 42 | 2.29 | 63.47 | WT | 1.41 |
NCI/ADR-RES | OV | 32 | 19 | 47 | 2.32 | 61.99 | WT | 64.64 |
HCC1143 | BRCA | 28 | 20 | 67 | 3.59 | 59.35 | WT | 1.26 |
HCC70 | BRCA | 29 | 23 | 57 | 3.22 | 59.13 | WT | 0.28 |
MX-1 | BRCA | 30 | 21 | 50 | 2.72 | 58.90 | BRCA1 c.2679_2682delGAAA p.K893Nfs*106 frameshift 99.84% | 2.40 |
OVCAR4 | OV | 29 | 19 | 55 | 3.12 | 54.67 | WT | 47.56 |
HCC1428 | BRCA | 17 | 17 | 53 | 3.62 | 30.82 | WT | 0.31 |
ZR-75-1 | BRCA | 9 | 15 | 40 | 3.20 | 14.42 | WT | 0.17 |
MDA-MB-453 | BRCA | 11 | 16 | 48 | 4.17 | 10.42 | WT | 0.45 |
MDA-MB-231 | BRCA | 11 | 11 | 30 | 2.78 | 8.90 | WT | 0.19 |
MDA-MB-361 | BRCA | 6 | 13 | 46 | 3.67 | 8.18 | WT | 1.91 |
MDA-MB-415 | BRCA | 9 | 13 | 34 | 3.09 | 8.10 | WT | 0.09 |
ZR-75-30 | BRCA | 7 | 13 | 41 | 3.67 | 4.10 | WT | 3.77 |
HS-578T | BRCA | 10 | 7 | 16 | 2.47 | − 5.33 | WT | 0.22 |
IGR-OV1 | OV | 7 | 0 | 7 | 1.85 | − 14.73 | BRCA1 c.1961delA p.K654Sfs*47 frameshift 50.07% | 0.15 |
A2780 | OV | 3 | 3 | 4 | 2.01 | − 21.19 | WT | 0.69 |